4 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 4 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Unknown 1 |
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 2 | 2 | Not yet recruiting 2 |
| Phase 4 | 2 | Recruiting 2 |
Follow Tiger Biosciences, LLC.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers PRFM, Standard of Care (SoC) - Diabetic Foot Ulcer (DFU), Ulcer | Phase 1 / Phase 2 | Not yet recruiting | Tiger Biosciences, LLC. | 55 | 2026-09-01 | 2026-09-25 |
| Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers PRFM - Lower Extremity, Chronic Ulcers | Phase 1 / Phase 2 | Not yet recruiting | Tiger Biosciences, LLC. | 30 | 2026-09-01 | 2026-10-07 |
| Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers ACApatch™, caregraFT™, Standard of Care - Pressure Ulcer, Ulcer | Phase 4 | Recruiting | Tiger Biosciences, LLC. | 500 | 2025-05-20 | 2026-09-23 |
| Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers. ACApatch™, caregraFT™, Standard of Care - Venous Leg Ulcer, Venous Leg | Phase 4 | Recruiting | Tiger Biosciences, LLC. | 340 | 2024-12-06 | 2026-09-22 |
| Autologous Fat Grafting to the Face With Use of the Viality™ System Viality - Adipose Tissue | Not applicable | Unknown | Tiger Biosciences, LLC. | 20 | 2023-11-13 | 2023-12-13 |
| AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast AuraGen 1-2-3 with AuraClens - Breast Fat Grafting Retention | Not applicable | Completed | Tiger Biosciences, LLC. | 200 | 2022-05-05 | 2026-08-05 |
| Tissue Expansion in Breast Reconstruction Without Drains Insertion of Tissue Expander with Fluid Reservoir - Breast Cancer, Hereditary Breast and Ovarian Cancer Syndrome | Completed | Cedars-Sinai Medical Center | 5 | 2019-02-25 | 2020-10-06 | |
| Post Market Clinical Experience Study of Sientra 207 Breast Implants Sientra 207 Silicone Gel Breast Implant - Breast Augmentation, Breast Revision-Augmentation | Terminated | Tiger Biosciences, LLC. | 113 | 2016-08-01 | 2023-07-03 | |
| Effects of Jet Hydro Dissection in Breast Augmentation Postoperative Pain Silicone Implant - Breast Augmentation | Not applicable | Completed | Aristocrat Plastic Surgery and MedAesthetics | 21 | 2014-11-01 | 2019-02-05 |
| Sientra Post-Approval Study Breast Augmentation, Breast Reconstruction | Active not recruiting | Tiger Biosciences, LLC. | 5498 | 2012-04-01 | 2026-09-22 | |
| Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study Silimed Gel-Filled Mammary Implant - Breast Augmentation, Breast Reconstruction | Not applicable | Completed | Tiger Biosciences, LLC. | 1788 | 2002-11-01 | 2024-01-11 |
Ulcer (3) · Diabetic Foot (2) · Pressure Ulcer (2) · Varicose Ulcer (2) · Breast Neoplasms (1) · Foot Ulcer (1) · Hereditary Breast and Ovarian Cancer Syndrome (1) · Leg Ulcer (1)
Standard of Care (3)
United States (9)
Denise Dajles, PhD (1) · Edward C Ray, MD (1) · Kevin Tehrani, M.D. (1) · Sara Saul (1) · Sara Saul, PhD (1) · Thomas Serena, MD (1)